Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain

被引:0
|
作者
Volkow, ND [1 ]
Wang, GJ
Fowler, JS
Logan, J
Gerasimov, M
Maynard, L
Ding, YS
Gatley, SJ
Gifford, A
Franceschi, D
机构
[1] Brookhaven Natl Lab, Dept Med, Upton, NY 11973 USA
[2] Brookhaven Natl Lab, Dept Chem, Upton, NY 11973 USA
[3] SUNY Stony Brook, Dept Psychiat, Stony Brook, NY 11794 USA
来源
JOURNAL OF NEUROSCIENCE | 2001年 / 21卷 / 02期
关键词
attention deficit hyperactivity disorder; raclopride; Ritalin; D2; receptors; striatum; positron emission tomography; imaging; dopamine transporters;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Methylphenidate (Ritalin) is the most commonly prescribed psychoactive drug in children for the treatment of attention deficit hyperactivity disorder (ADHD), yet the mechanisms responsible for its therapeutic effects are poorly understood. Whereas methylphenidate blocks the dopamine transporter (main mechanism for removal of extracellular dopamine), it is unclear whether at doses used therapeutically it significantly changes extracellular dopamine (DA) concentration. Here we used positron emission tomography and [C-11] raclopride (D2 receptor radioligand that competes with endogenous DA for binding to the receptor) to evaluate whether oral methylphenidate changes extracellular DA in the human brain in 11 healthy controls. We showed that oral methylphenidate (average dose 0.8 +/- 0.11 mg/kg) significantly increased extracellular DA in brain, as evidenced by a significant reduction in B-max/K-d (measure of D2 receptor availability) in striatum (20 +/- 12%; p < 0.0005). These results provide direct evidence that oral methylphenidate at doses within the therapeutic range significantly increases extracellular DA in human brain. This result coupled with recent findings of increased dopamine transporters in ADHD patients (which is expected to result in reductions in extracellular DA) provides a mechanistic framework for the therapeutic efficacy of methylphenidate. The increase in DA caused by the blockade of dopamine transporters by methylphenidate predominantly reflects an amplification of spontaneously released DA, which in turn is responsive to environmental stimulation. Because DA decreases background firing rates and increases signal-to-noise in target neurons, we postulate that the amplification of weak DA signals in subjects with ADHD by methylphenidate would enhance task-specific signaling, improving attention and decreasing distractibility. Alternatively methylphenidate-induced increases in DA, a neurotransmitter involved with motivation and reward, could enhance the salience of the task facilitating the "interest that it elicits" and thus improving performance.
引用
收藏
页码:U1 / U5
页数:5
相关论文
共 44 条
  • [1] Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate
    Volkow, ND
    Wang, GJ
    Fowler, JS
    Gatley, SJ
    Logan, J
    Ding, YS
    Hitzemann, R
    Pappas, N
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 1998, 155 (10): : 1325 - 1331
  • [2] Therapeutic doses of amphetamine or methylphenidate differentially increase synaptic and extracellular dopamine
    Schiffer, WK
    Volkow, ND
    Fowler, JS
    Alexoff, DL
    Logan, J
    Dewey, SL
    [J]. SYNAPSE, 2006, 59 (04) : 243 - 251
  • [3] Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: Therapeutic implications
    Volkow, ND
    Wang, GJ
    Fowler, JS
    Logan, J
    Franceschi, D
    Maynard, L
    Ding, YS
    Gatley, SJ
    Gifford, A
    Zhu, W
    Swanson, JM
    [J]. SYNAPSE, 2002, 43 (03) : 181 - 187
  • [4] Plasma and brain concentrations of oral therapeutic doses of methylphenidate and their impact on brain monoamine content in mice
    Balcioglu, Aygul
    Ren, Jia-Qian
    McCarthy, Deirdre
    Spencer, Thomas J.
    Biederman, Joseph
    Bhide, Pradeep G.
    [J]. NEUROPHARMACOLOGY, 2009, 57 (7-8) : 687 - 693
  • [5] Effect of repeated oral therapeutic doses of methylphenidate on food intake and growth rate in rats
    Alam, Nausheen
    Najam, Rahila
    [J]. PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 28 (01) : 9 - 13
  • [6] Effects of therapeutic and abusive doses of methylphenidate on neurogenesis and neuronal survival rates in murine brain
    DeVee, Carley
    Farmer, Brandon
    Hanley, Angela
    Pond, Brooks
    [J]. FASEB JOURNAL, 2014, 28 (01):
  • [7] RAPID POSTMORTEM INCREASE IN EXTRACELLULAR DOPAMINE IN THE RAT-BRAIN AS ASSESSED BY BRAIN MICRODIALYSIS
    VULTO, AG
    SHARP, T
    UNGERSTEDT, U
    VERSTEEG, DHG
    [J]. JOURNAL OF NEUROCHEMISTRY, 1988, 51 (03) : 746 - 749
  • [8] Differential effects of adjunctive methylphenidate and citalopram on extracellular levels of serotonin, noradrenaline and dopamine in the rat brain
    Weikop, Pia
    Yoshitake, Takashi
    Kehr, Jan
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 (10) : 658 - 671
  • [9] Evidence that methylphenidate enhances the saliency of a mathematical task by increasing dopamine in the human brain
    Volkow, ND
    Wang, GJ
    Fowler, JS
    Telang, F
    Maynard, L
    Logan, J
    Gatley, SJ
    Pappas, N
    Wong, C
    Vaska, P
    Zhu, W
    Swanson, JM
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2004, 161 (07): : 1173 - 1180
  • [10] EXOGENOUS TYROSINE POTENTIATES THE METHYLPHENIDATE-INDUCED INCREASE IN EXTRACELLULAR DOPAMINE IN THE NUCLEUS-ACCUMBENS - A MICRODIALYSIS STUDY
    WOODS, SK
    MEYER, JS
    [J]. BRAIN RESEARCH, 1991, 560 (1-2) : 97 - 105